Business context and reporting period
Noah Holdings Limited’s Form 20-F reports the fiscal year ended December 31, 2022; it is an annual report, not a standalone fourth-quarter filing. Noah is a Cayman Islands holding company providing wealth management and asset management services primarily to high-net-worth clients. Financial statements are prepared under U.S. GAAP and audited by Deloitte, which issued an unqualified opinion. Management and the auditor reported effective internal control over financial reporting as of year-end.
The wealth management, asset management and other businesses accounted for 71.0%, 26.9% and 2.1% of 2022 net revenue, respectively. The company operates partly through PRC affiliated entities consolidated under contractual arrangements rather than direct equity ownership.
Key financial metrics
Unless otherwise noted, amounts are RMB; 2022 U.S. dollar equivalents are shown where useful. Revenue and profit figures below are for the full fiscal year.
| Metric | 2022 | 2021 |
|---|---|---|
| Net revenue | RMB3.100bn (US$449.5m) | RMB4.293bn |
| Operating income | RMB1.088bn | RMB1.199bn |
| Operating margin | 35.1% | 27.9% |
| Net income attributable to Noah shareholders | RMB976.6m (US$141.6m) | RMB1.314bn |
| Net margin attributable to shareholders | 31.5% | 30.6% |
| Adjusted net income attributable to shareholders (non-GAAP) | RMB1.009bn (US$146.2m) | RMB1.373bn |
| Net cash from operating activities | RMB632.9m (US$91.8m) | RMB1.522bn |
| Cash and cash equivalents | RMB4.404bn (US$638.5m) | RMB3.405bn |
| Total assets / total liabilities | RMB11.798bn / RMB2.298bn | RMB10.890bn / RMB2.748bn |
Year-end current assets were RMB6.317bn and current liabilities RMB1.905bn. The filing does not provide a clear consolidated borrowings or debt balance in the supplied text; operating lease liabilities were RMB167.5m. Management said existing cash and expected operating cash flow should meet needs for at least the next 12 months. 2022 capital expenditure was RMB62.7m; estimated 2023 capex was RMB157.8m, mainly for headquarters renovations.
Operating cash flow fell from 2021. Investing activities provided RMB74.3m in 2022, versus RMB2.572bn used in 2021, when major spending included the Shanghai headquarters purchase. Financing activities provided RMB233.8m in 2022, including RMB247.0m of net proceeds from the Hong Kong listing. The company reported no off-balance-sheet guarantees or specified third-party financing support arrangements.
Material changes versus the prior comparable period
- Net revenue declined 27.8%, driven by lower one-time commissions, recurring service fees and performance-based income. Distribution transaction value fell 27.7% to RMB70.3bn; private secondary product transaction value dropped substantially, while mutual fund transaction value rose.
- Operating costs and expenses fell 35.0%, reflecting lower relationship-manager compensation and cost controls. Operating income nevertheless declined 9.2%; attributable net income fell 25.7%, and non-GAAP adjusted net income fell about 26.5%.
- Wealth management net revenue decreased 31.1% to RMB2.200bn. Asset management net revenue decreased 19.9% to RMB834.5m, despite AUM increasing 0.7% to RMB157.1bn. Private equity represented 84.7% of AUM.
- Active clients including mutual-fund-only clients declined from 42,764 to 35,877. Active clients excluding mutual-fund-only clients declined from 12,831 to 6,520.
- Operating margin improved year over year as expenses declined faster than revenue. 2021 also included higher performance-based income and a one-time credit-product liquidation fee effect on recurring fees.
Outlook, risks, contingencies and unusual items
The filing provides no specific earnings or revenue guidance. Management cites macroeconomic and market volatility, COVID-related disruption during 2022, investment performance, client redemptions, fee rates and product-partner relationships as factors affecting results. The company had reduced its lending activity and discontinued substantially all private-credit product offerings, shifting toward standardized public securities products and long-duration private equity.
- Contingencies: The company recorded RMB568.0m of contingent liabilities at year-end, including RMB469.0m related to potential future Camsing settlements and RMB99.0m for an adverse first-instance court ruling under appeal, plus applicable interest. The company says it intends to contest the latter ruling.
- Camsing: 595 of 818 affected investors had accepted the voluntary settlement offer by year-end, representing RMB2.6bn of the RMB3.4bn potentially defaulted investments. Potential shares for settling clients could equal approximately 9.3% of issued shares at year-end, creating dilution risk. No new settlement was recorded in 2022.
- PRC structure and regulation: A significant part of asset management revenue is generated through affiliated entities controlled by contractual arrangements. Their enforceability, evolving PRC regulation, overseas offering filings, data and cybersecurity rules, foreign-exchange restrictions and limits on moving funds out of China pose material risks. The affiliated entities contributed 41.4% of 2022 net revenue.
- Audit access and listing: The PCAOB vacated its 2021 determination concerning China and Hong Kong audit inspections in December 2022. The filing warns that future loss of inspection access could again create HFCA Act trading-prohibition risk.
- Dividend: The board recommended a final 2022 cash dividend of RMB5.5 per ordinary share, approximately RMB176.5m in aggregate, subject to shareholder approval. The dividend policy is not a binding commitment.
- Other: The company identified itself as a PFIC for U.S. federal tax purposes for 2022. Government subsidies of RMB129.5m were received in 2022 and are described as non-recurring. The 2022 Hong Kong offering raised RMB247.0m net; none of the proceeds had been used by year-end.
Important facts for investors to verify
- Review the audited financial statements and the drivers of lower revenue, earnings and operating cash flow; distinguish GAAP results from the company’s non-GAAP adjusted measure.
- Assess the quality and collectability of receivables, related-party balances and loans, including the RMB93.9m allowance for loan losses and RMB465.8m net loans receivable.
- Track the appeal and subsequent proceedings on the RMB99.0m judgment, Camsing settlement progress, remaining investor claims and possible share dilution.
- Confirm shareholder approval and payment details for the proposed dividend, and whether the stated 2023 capital expenditure is realized.
- Monitor AUM composition, performance-fee realization, client activity, product transaction values and the company’s reliance on limited product partners.
- Evaluate the VIE/contractual-arrangement exposure, PRC regulatory developments, cash-transfer restrictions and continued PCAOB inspection access.